Evidence map›Paper›PMID 24947124›Full record

ArticleAnalytical chemistry2014

Folding-upon-binding and signal-on electrochemical DNA sensor with high affinity and specificity.

Andrea Idili, Alessia Amodio, Marco Vidonis, Jacob Feinberg-Somerson, Matteo Castronovo, Francesco Ricci

Abstract read
In one paragraph

Article in Analytical chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Applications of triplex DNA nanostructures in sensor development.Analytical and bioanalytical chemistry · 2022
    Review
  5. Programmable Cell-Free Transcriptional Switches for Antibody Detection.Journal of the American Chemical Society · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea IdiliDipartimento di Scienze e Tecnologie Chimiche, University of Rome, Tor Vergata , Via della Ricerca Scientifica 1, 00133 Rome, Italy.
Alessia Amodio
Marco Vidonis
Jacob Feinberg-Somerson
Matteo Castronovo
Francesco Ricci

Funding

Personalized, high-resolution pharmacokinetic measurements to improve drug dosingF31CA183385 · NCI · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SOMERSON, JACOB · 2014 to 2016
$107k
European Research Council 269051NCI NIH HHS F31 CA183385NCI NIH HHS F31CA183385
6 · The paper itself

Abstract

Here we investigate a novel signal-on electrochemical DNA sensor based on the use of a clamp-like DNA probe that binds a complementary target sequence through two distinct and sequential events, which lead to the formation of a triplex DNA structure. We demonstrate that this target-binding mechanism can improve both the affinity and specificity of recognition as opposed to classic probes solely based on Watson-Crick recognition. By using electrochemical signaling to report the conformational change, we demonstrate a signal-on E-DNA sensor with up to 400% signal gain upon target binding. Moreover, we were able to detect with nanomolar affinity a perfectly matched target as short as 10 bases (K(D) = 0.39 nM). Finally, thanks to the molecular "double-check" provided by the concomitant Watson-Crick and Hoogsteen base pairings involved in target recognition, our sensor provides excellent discrimination efficiency toward a single-base mismatched target.

Indexed as

Electrochemical TechniquesBase Pair MismatchDNADNA ProbesElectrodesMethylene BlueMicroscopy, Atomic ForceNucleic Acid HybridizationOxidation-ReductionDNADNA ProbesMethylene Blue

Identifiers

PMID24947124
PMCPMC4165453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.